Involvement of endogenous opiates in regulation of gastric emptying of fat test meals in mice.
The role of endogenous opioids and cholecystokinin (CCK) in gastric emptying was investigated in mice killed 30 min after gavage with 51Cr-radiolabeled liquid meals. The meals consisted of 0.5 ml of milk or one of five synthetic meals containing arabic gum, glucose and/or arachis oil and/or casein. Naloxone (0.1 mg/kg sc) significantly (P less than 0.01) accelerated gastric emptying of milk and meals containing fat but did not modify gastric emptying of nonfat meals. The CCK antagonist asperlicin (0.1 mg/kg ip) increased by 25% gastric emptying of milk. The gastric emptying of meals containing glucose and casein but not fat was reduced after administration of the COOH-terminal octapeptide of cholecystokinin (CCK-8, 4 micrograms/kg ip). This decrease was antagonized by both asperlicin (10 mg/kg ip) and naloxone (0.1 mg/kg sc). Intracerebroventricular (icv) administration of an opiate antagonist that poorly crosses the blood-brain barrier, methyl levallorphan (10 micrograms/kg), did not modify gastric emptying of milk but accelerated it when peripherally administered (0.1 mg/kg sc). Similarly, asperlicin (icv) administered at a dose of 1 mg/kg did not affect milk emptying. These results indicate that endogenous opiates are involved at peripheral levels in the regulation of gastric emptying of fat meals only and that such regulation involves release of CCK.
Fioramonti
J
J
Department of Pharmacology, Institut National de la Recherche Agronomique, Toulouse, France.
Fargeas
M J
MJ
Bueno
L
L
D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology; D002766:Cholecystokinin / Q000037:antagonists & inhibitors; D002860:Chromium Radioisotopes; D004041:Dietary Fats; D004723:Endorphins / Q000502:physiology*; D005746:Gastric Emptying / Q000187:drug effects; D006706:Homeostasis; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009270:Naloxone / Q000494:pharmacology; D012016:Reference Values; D012844:Sincalide / Q000494:pharmacology*
D001570:Benzodiazepinones; D002860:Chromium Radioisotopes; D004041:Dietary Fats; D004723:Endorphins; D009270:Naloxone; D002766:Cholecystokinin; D012844:Sincalide; C046367:asperlicin